Clearmind Medicine Inc. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Clearmind Medicine Inc. on November 20, 2024, covering the month of November 2024. The filing serves as a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the scheduling of a shareholder meeting.
Guidance, Outlook, and Corporate Actions
The Company announced it will hold an Annual and Special Meeting of Shareholders on January 6, 2025. The record date for shareholders eligible to vote is set for November 28, 2024. Proxy materials, including the full version of proposed resolutions, will be distributed to shareholders of record after the record date. This filing incorporates by reference into the Company's Registration Statements on Form F-3.
Key Facts for Investor Verification
- Meeting Date: Annual and Special Meeting of Shareholders scheduled for January 6, 2025.
- Record Date: November 28, 2024.
- Document Type: Procedural notice (Form 6-K) with no financial data included.
- Exhibit: Notice of Annual and Special Meeting of Shareholders is attached as Exhibit 99.1.